Invasive Care
| | | | | | |
Grines, CL
|
X
|
X
|
X
|
In-hospital complications
|
20/237 (8.4%)
|
20/234 (8.5%) N.S.
|
1998
| | | |
Re-hospitalisation (6 months)
|
10/237 (4.2%)
|
9/234 (3.9%) N.S.
|
Swanson, CE
|
X
|
Not
|
X
|
Hospital mortality
|
2/38 (5.2%)
|
2/33 (6.1%) N.S.
|
1998
| |
sure
| |
Mean Modified Barthel Index
|
92.8
|
85.6 (p < 0.05)
|
Dowsey, MM
|
X
|
X
|
X
|
In-hospital complications
|
10/92 (10.8%)
|
20/71 (28.1%) (p < 0.05)
|
1999
| | | |
Re-hospitalisation (3 months)
|
1/92 (1.1%)
|
0/71 (0%) N.S.
|
Choong, PF
|
X
|
X
|
X
|
In-hospital complications
|
10/55 (18.2%)
|
14/56 (25.0%) N.S.
|
2000
| | | |
Re-hospitalisation (28 days)
|
2/55 (3.6%)
|
6/56 (10.7%) N.S.
|
Aizawa, T
|
X
|
X
|
X
|
In-hospital complications
|
1/32 (3.1%)
|
2/37 (5.4%) N.S.
|
2002
| | | |
Re-hospitalisation (6 months)
|
1/32 (3.1%)
|
0/37 (0%) N.S.
|
Kiyama, T
|
X
|
X
|
X
|
In-hospital complications
|
3/47 (6.4%)
|
5/38 (13.2%) N.S.
|
2003
| | | | | | |
Hirao, M
|
X
|
X
|
X
|
In-hospital complications
|
19/53 (35.8%)
|
17/50 (34.0%) N.S.
|
2005
| | | |
Re-hospitalisation (6 months)
|
0/53 (0%)
|
0/50 (0%)
|
Non-Invasive Care
| | | | | | |
Falconer, JA
|
X
|
Not
|
X
|
Mortality (12 months)
|
N.S.
|
N.S.
|
1993
| |
Sure
| |
Re-hospitalisation (12 months)
|
N.S.
|
N.S.
|
| | | |
Cognitive and functional scores (0–100)
|
N.S.
|
N.S.
|
| | | |
Patient satisfaction
|
7.7 (SD 2.6)
|
8.8 (SD 1.7) (p < 0.05)
|
Gomez, MA
|
X
|
X
|
X
|
Complete and graded exercise test
|
44/50 (88.0%)
|
15/50 (30.0%)
|
1996
| | | | | | |
Roberts, RR
|
X
|
X
|
X
|
Hospitalised patients as %
|
(45.1%)
|
(100%)
|
1997
| | | |
Re-hospitalisation (8 weeks)
|
5/82 (6.1%)
|
4/83 (4.8%) N.S.
|
Johnson, KB 2000
|
X
|
X
|
X
|
Unscheduled clinic visits; no hospital re-admission (2 weeks)
|
0/55 (0%)
|
2/55 (3.6%)
|
Kollef, HM
|
X
|
X
|
X
|
In-hospital complications
|
9/239 (3.8%)
|
13/250 (5.2%) N.S.
|
2000
| | | |
Hospital mortality
|
5/239 (2.1%)
|
8/250 (3.2%) N.S.
|
Marrie, TJ 2000
|
X
|
X
|
X
|
Absolute difference in rates (ARR) between pathway and control
| |
1-sided 95% CI upper limit:
|
| | | |
In-hospital complications
|
(0.6%)
|
(4.6%) N.S.
|
| | | |
Re-hospitalisation (6 weeks)
|
(0.7%)
|
(3.6%) N.S.
|
| | | |
Mortality (6 weeks)
|
(-0.1%)
|
(2.5%) N.S.
|
Sulch, D
|
X
|
X
|
X
|
Median Barthel Index Score (26 weeks)
|
17
|
17 N.S.
|
1999
| | | |
Mortality (26 weeks)
|
10/76 (13.2%)
|
6/76 (7.9%) N.S.
|
Kim, MH
|
X
|
X
|
X
|
Complications until follow-up (27 days)
|
1/9 (11.1%)
|
1/9 (11.1%) N.S.
|
2002
| | | |
Re-hospitalisation (27 days)
|
2/9 (22.2%)
|
0/9 (0%) N.S.
|
Chen, SH 2004
|
X
|
X
|
X
|
Emergency room usage (not comparable with in-hospital complications)
|
3/20 (15.0%)
|
13/22 (59.1%) (p < 0.05)
|
| | | |
Re-hospitalisation (3 months)
|
N.S.
|
N.S.
|
Usui, K 2004
|
X
|
X
|
X
|
Not reported
| | |